Clinical trial
DNA Chip Based Prognosis of Lung Cancer
NCT00973427 is registered in ClinicalTrials.gov with Medical Prognosis Institute A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DNA Chip Based Prognosis of Lung Cancer
- Lead sponsor
- Medical Prognosis Institute A/S
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- September 30, 2014
- Enrollment
- 144 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.